Evidence map›Paper›PMID 35545683›Full record

SynthesisJournal of neurology2022

A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility.

Melissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, Santosh Anand, Sara Lupoli, Erika Salvi, Eleonora Mangano, Roberta Bordoni, Tina Roostaei, Elisabetta Mascia and 19 more

Erratum issuedOpen access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Improved chromatin QTL mapping with CACTI.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 8 institutions in 2 countries.

Melissa Sorosina *Laboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Nadia Barizzone *Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Avogadro University, 28100, Novara, Italy.
Ferdinando ClarelliLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Santosh AnandDepartment of Informatics, Systems and Communications (DISCo), University of Milano-Bicocca, Milan, Italy.
Sara LupoliDepartment of Health Sciences, University of Milan, 20139, Milan, Italy.
Erika SalviDepartment of Health Sciences, University of Milan, 20139, Milan, Italy.
Eleonora ManganoNational Research Council of Italy, Institute for Biomedical Technologies, Segrate, 20090, Milan, Italy.
Roberta BordoniNational Research Council of Italy, Institute for Biomedical Technologies, Segrate, 20090, Milan, Italy.
Tina RoostaeiCenter for Translational and Computational Neuroimmunology, Department of Neurology and the Taub Institute for Research On Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Elisabetta MasciaLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Miriam ZuccalàDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Avogadro University, 28100, Novara, Italy.
Domizia VecchioMS Centre, SCDU Neurology, AOU Maggiore Della Carità, Department of Translational Medicine, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont Avogadro, 28100, Novara, Italy.
Paola CavallaMS Center, Department of Neuroscience and Mental Health, City of Health and Science University Hospital of Torino, 10126, Turin, Italy.
Silvia SantoroLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Laura FerrèLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Alen ZolloDepartment of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan, 20122, Milan, Italy.
PROGEMUS
Cristina BarlassinaDepartment of Health Sciences, University of Milan, 20139, Milan, Italy.
Daniele CusiNational Research Council of Italy, Institute for Biomedical Technologies, Segrate, 20090, Milan, Italy.
Vittorio MartinelliNeurology Unit, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Giancarlo ComiNeurology Unit, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Maurizio LeoneSC Neurologia, Dipartimento Di Scienze Mediche, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
Massimo FilippiNeurology Unit, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Nikolaos A PatsopoulosSystems Biology and Computer Science Program, Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Philip L De JagerCenter for Translational and Computational Neuroimmunology, Department of Neurology and the Taub Institute for Research On Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Gianluca De BellisNational Research Council of Italy, Institute for Biomedical Technologies, Segrate, 20090, Milan, Italy.
Federica Esposito *Laboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Sandra D'Alfonso *Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Avogadro University, 28100, Novara, Italy.
Filippo Martinelli Boneschi *Department of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan, 20122, Milan, Italy. filippo.martinelli@unimi.it.ORCID http://orcid.org/0000-0002-9955-1368
Vita-Salute San Raffaele University · ITUniversity of Milan · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITInstitute of Biomedical Technologies · ITBroad Institute · USColumbia University · USFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milano-Bicocca · IT

Funding

Fondazione Italiana Sclerosi Multipla 2011/R/14Fondazione Italiana Sclerosi Multipla 2013/R/13Fondazione Italiana Sclerosi Multipla 2015/R/10Fondazione Italiana Sclerosi Multipla 2019/R-Multi/033Fondazione Italiana Sclerosi Multipla 2019/S/4HYPERGENES HEALTH-F4-2007-201550Ministero della Salute RF-2016-02361294National Multiple Sclerosis Society JF-1808-32223National Multiple Sclerosis Society RG-1707-28657Università degli Studi del Piemonte Orientale AGING Project for Department of Excellence at the Department of Translational Medicine
6 · The paper itself

Abstract

backgroundOver 200 genetic loci have been associated with multiple sclerosis (MS) explaining ~ 50% of its heritability, suggesting that additional mechanisms may account for the "missing heritability" phenomenon.

objectiveTo analyze a large cohort of Italian individuals to identify markers associated with MS with potential functional impact in the disease.

methodsWe studied 2571 MS and 3234 healthy controls (HC) of continental Italian origin. Discovery phase included a genome wide association study (1727 MS, 2258 HC), with SNPs selected according to their association in the Italian cohort only or in a meta-analysis of signals with a cohort of European ancestry (4088 MS, 7144 HC). Top associated loci were then tested in two Italian cohorts through array-based genotyping (903 MS, 884 HC) and pool-based target sequencing (588 MS, 408 HC). Finally, functional prioritization through conditional eQTL and mQTL has been performed.

resultsTop associated signals overlap with already known MS loci on chromosomes 3 and 17. Three SNPs (rs4267364, rs8070463, rs67919208), all involved in the regulation of TBKBP1, were prioritized to be functionally relevant.

conclusionsNo evidence of novel signal of association with MS specific for the Italian continental population has been found; nevertheless, two MS loci seems to play a relevant role, raising the interest to further investigations for TBKBP1 gene.

Indexed as

Genome-Wide Association StudyMultiple SclerosisAdaptor Proteins, Signal TransducingGenetic Predisposition to DiseaseGenomicsGenotypeHumansPolymorphism, Single NucleotideAdaptor Proteins, Signal TransducingTBKBP1 protein, humanGeneticsGenome-wide association studyMultiple sclerosisSusceptibilityTBKBP1

Identifiers

PMID35545683
PMCPMC9294010
OpenAlexW4280558619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.